MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-HR-03-0007655
Glensmith Labs Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹120.6 Cr
▲ 16% YoY
Net profit · FY 2025
₹5.06 Cr
Net margin 4.2%
EBITDA · FY 2025
₹8.93 Cr
EBITDA margin 7.4%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹16.38 Cr
Secured borrowings
Company age
12 yrs
Est. 2014
Employees · EPFO
217
Provident fund records
About Glensmith Labs Private Limited
Data last updated:
Glensmith Labs Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 November 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2014PTC273104. Its GSTIN is 06AAACY7067N1ZQ (Haryana). The company holds 4 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹10 Lakh. It was formerly known as Yours Medicare Private Limited. It is led by directors Sanjay Gupta and Manish Garg.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 302 Narmada Block – 5 Pocket D – 6 Vasant Kunj, New Delhi, Delhi, India – 110070.
As per the financials filed for FY 2025, the company reported a revenue of ₹120.6 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹5.06 Cr (net margin 4.2%) and EBITDA of ₹8.93 Cr (EBITDA margin 7.4%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 21% over five years.
The company has about 217 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Glensmith Labs. As per MCA filings, the company has open charges of ₹16.38 Cr on record. Court records list 14 cases involving the company, including 10 filed by the company and 4 filed against it; 1 case is pending.
Glensmith Labs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-03-0007655). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website glensmith.co.in.
Company details
CIN U24100DL2014PTC273104
Registration Number 273104
Incorporation Date 12 November 2014
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-HR-03-0007655
Key People
Sanjay Gupta Director Manish Garg Director Recognitions & Rankings of Glensmith Labs
Contact details
Glensmith Labs Private Limited's registered office is in New Delhi, Delhi. Its website is glensmith.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address302 Narmada Block – 5 Pocket D – 6 Vasant Kunj, New Delhi, Delhi, India – 110070
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Glensmith Labs Private Limited, buy the company report.
Comprehensive company report
Glensmith Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Glensmith Labs operates one associated brand: Glensmith Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical product development, manufacturing, and marketing in India. | glensmith.co.in |
Business activity
The main business activity of Glensmith Labs is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Glensmith Labs Private Limited, buy the company report.
Financials of Glensmith Labs Private Limited
FY 2025 filings availableGlensmith Labs Private Limited reported revenue of ₹120.6 Cr (up 16% YoY) for FY 2025.
Revenue · FY 2025
₹120.6 Cr ▲ 16%
Net profit · FY 2025
₹5.06 Cr margin 4.2%
EBITDA · FY 2025
₹8.93 Cr margin 7.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 6%
5 years · compounded
▲ 21%
EBITDA CAGR growth
1 year
▲ 171%
3 years · compounded
▲ 20%
5 years · compounded
▲ 67%
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 16% growth in the latest year. EBITDA rose 171% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹120.6 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.93 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.06 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.4% | ||||
| Net Profit Margin | 4.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Glensmith Labs Private Limited, buy the company report.
Board of directors of Glensmith Labs Private Limited
Glensmith Labs has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Gupta Also directs: MKS Healthcare Private Limited, Cosmax Pharma Private Limited, Skymap Packaging Private Limited and 5 more | Director | 12 Nov 2014 | 11 Years 11 Months | Current |
| Manish Garg Also directs: Cosmax Pharma Private Limited, Skymap Pharmaceuticals Private Limited, Nortis Lifesciences Private Limited and 1 more | Director | 15 Feb 2015 | 11 Years 8 Months | Current |
Peer comparison
Glensmith Labs Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ihl Lifesciences Private Limited | ₹122.51 Cr (FY 2025) | 14.0% | Indore, Madhya Pradesh, India | |||
| Camus Pharma Private Limited | ₹121.82 Cr (FY 2025) | 68.0% | Jaipur, Rajasthan, India | |||
| Glensmith Labs Private Limitedthis company | ₹120.6 Cr (FY 2025) | ₹5.06 Cr | 4.2% | 16.0% | 217 | New Delhi, Delhi, India |
| Alniche Lifesciences Private Limited | ₹120.36 Cr (FY 2025) | -56.0% | New Delhi, Delhi, India | |||
| Aquatic Formulations (India) Limited | ₹120.14 Cr (FY 2025) | 25.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Glensmith Labs Private Limited, buy the company report.
Auditor
Glensmith Labs Private Limited is audited by Singla Tayal and Company for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Singla Tayal and Company | FY 2023 | 000882N |
Shareholding
The shareholding of Glensmith Labs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Glensmith Labs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹16.38 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Jun 2026 | 101316295 | Hdfc Bank Limited | ₹2.28 Cr | Open | |
| 30 Mar 2015 | 10567359 | Hdfc Bank Limited | ₹14.1 Cr | Open |
To see the full charge records of Glensmith Labs Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Glensmith Labs Private Limited has 14 court cases on record: 10 filed by Glensmith Labs, 4 filed against it. 1 case is pending and 13 are disposed.
Total cases
14
Filed by the company
10
Filed against the company
4
Pending
1
Disposed
13
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 12 | 2 | 1 |
| High courts | 2 | 2 | 0 |
Cases on record (5 of 14)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Court case (CS (COMM.)) | Filed against the company by Wings Pharmaceuticals Pvt. Ltd. | Disposed |
| High Court of Delhi | Commercial suit | Filed against the company by Abbott Healthcare Private Limited | Disposed |
| District court, Faridabad, Haryana | Cheque dishonour complaint | Filed by the company against S.M.P.L Life Sciences Pvt Ltd and 3 others | Disposed |
| District court, Faridabad, Haryana | Cheque dishonour complaint | Filed by the company against M/S R.C. Drug Agency | Pending |
| District court, Faridabad, Haryana | Criminal miscellaneous application | Filed by the company against Mahavir Enterprises | Disposed |
To see the full case history of Glensmith Labs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Glensmith Labs Private Limited has 3 MSME Form 1 returns on record between 2019 and 2020, listing 38 overdue payments to 15 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 15)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Affy Parenterals | |||
| Prochem Pharmaceuticals Private Limited | |||
| Avalon Biocares | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Glensmith Labs Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Glensmith Labs Private Limited has a workforce of 217 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
Employee count
217
Active EPFO establishments
1
Employee growth
-19.93%
GST
Glensmith Labs has 4 GST registrations: 3 active and 1 cancelled or inactive.
Total GSTINs
4
Active
3
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAACY7067N1ZQ | Haryana | Active | 01 Jul 2017 |
| 23AAACY7067N1ZU | Madhya Pradesh | Active | 01 Nov 2022 |
| 08AAACY7067N1ZM | Rajasthan | Active | 07 Aug 2023 |
To see the full GST registrations and return filing status of Glensmith Labs Private Limited, buy the company report.
Recent activity
Glensmith Labs Private Limited has 4 board changes on record since 2014: 2 appointments and 2 cessations. The latest: Manish Gupta ceased to be Director on 09 Oct 2016.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 227.70 Lakh with Charge ID 101316295 was registered on 20 Jun 2026.
Charges
A charge with Hdfc Bank Limited of Rs. 1,410.00 Lakh registered on 30 Mar 2015 with Charge ID 10567359 was modified on 23 Mar 2026.
AGM
Glensmith Labs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Glensmith Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Ceased
Manish Gupta ceased to be Director.
Ceased
Manish Garg ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1,410.00 Lakh with Charge ID 10567359 was registered on 30 Mar 2015.
Appointed
Manish Garg was appointed as Director.
Appointed
Sanjay Gupta was appointed as Director.
Incorporation
12 Nov 2014
Glensmith Labs Private Limited was registered on 12 Nov 2014 with Roc Delhi I & aged 11 years 11 months as per MCA records.
Frequently asked questions
Glensmith Labs is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 November 2014 (12+ years old) and is registered under CIN U24100DL2014PTC273104.
Glensmith Labs has 2 current directors:
- Sanjay Gupta - Director
- Manish Garg - Director
The latest financial statements of Glensmith Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Glensmith Labs is 06AAACY7067N1ZQ, registered in Haryana. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 23AAACY7067N1ZU (Madhya Pradesh), 08AAACY7067N1ZM (Rajasthan).
The CIN (Corporate Identification Number) of Glensmith Labs is U24100DL2014PTC273104. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Glensmith Labs has 14 court cases on record: 10 filed by the company and 4 filed against it. 1 is pending. Most are in the district courts.
Glensmith Labs was incorporated on 12 November 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Glensmith Labs by revenue are Ihl Lifesciences Private Limited, Camus Pharma Private Limited, Alniche Lifesciences Private Limited, Aquatic Formulations (India) Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Manish Gupta ceased to be Director on 09 Oct 2016. Manish Garg ceased to be Additional Director on 30 Sep 2015. Manish Garg was appointed as Director on 15 Feb 2015. Glensmith Labs has 4 board changes on record in total.
Yes, Glensmith Labs is registered as a medium enterprise under Udyam registration (number: UDYAM-HR-03-0007655).
Glensmith Labs has 3 MSME Form 1 returns on record between 2019 and 2020, listing 38 overdue payments to 15 micro and small suppliers. The latest return was filed on 08 Aug 2020.
Glensmith Labs can be reached through the website glensmith.co.in. Its registered office is in New Delhi, Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages